A Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).

NCT01266499 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Klebsiella Pneumoniae Carbapenemase Resistant Associated Bacteremia or Pneumonia

Interventions

DRUG: Colistin (Polymyxin E) 100mg x 4/d
DRUG: both medications
DRUG: will not receive PO treatment
DRUG: PO Garamycin 80mg x 4/d

Sponsor

Rambam Health Care Campus